New York State Common Retirement Fund’s aTyr Pharma ATYR Stock Holding History

New York State Common Retirement Fund’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.4K	Hold	27,500	–	–	﹤0.01%	3005
2025 Q4	$21.5K	Hold	27,500	–	–	﹤0.01%	3078
2025 Q3	$19.8K	Hold	27,500	–	–	﹤0.01%	3108
2025 Q2	$139K	Buy	+27,500	New	+$108K	﹤0.01%	2412
2016 Q3	–	Sell	-393	Closed	-$15K	–	3164
2016 Q2	$15K	Hold	393	–	–	﹤0.01%	3153
2016 Q1	$22K	Hold	393	–	–	﹤0.01%	3115
2015 Q4	$54K	Hold	393	–	–	﹤0.01%	3103
2015 Q3	$56K	Buy	393 +113	+40%	+$25.8K	﹤0.01%	3108
2015 Q2	$73K	Buy	+280	New	+$87K	﹤0.01%	3165

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York State Common Retirement Fund's ATYR Position: Q1 2026 in Review

New York State Common Retirement Fund held its aTyr Pharma (ATYR) position steady in Q1 2026 at 27,500 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3005.

New York State Common Retirement Fund first reported a position in ATYR in Q2 2015 and has held it in 9 quarters since. The position peaked at $139K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

New York State Common Retirement Fund held 27,500 shares of aTyr Pharma worth $21.4K as of Q1 2026.
New York State Common Retirement Fund left its aTyr Pharma share count unchanged in Q1 2026.
aTyr Pharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #3005 holding.
New York State Common Retirement Fund first reported a position in aTyr Pharma in Q2 2015 and has held it in 9 quarters since.
New York State Common Retirement Fund's aTyr Pharma position peaked at $139K in Q2 2025.
111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.